Home » Topics » Regulatory

Regulatory
RSS

New use for sPLA2 inhibitor claimed by Lilly: LY-315920 for IBS

Dec. 23, 1999

FDA is first agency worldwide to approve new fluoroquinolone for marketing

Dec. 22, 1999

Dexmedetomidine receives FDA marketing approval

Dec. 22, 1999

FDA approves topical treatment for nail fungus

Dec. 21, 1999

Schwarz sells intranasal scopolamine rights to Nastech

Dec. 21, 1999

Swiss regulatory authorities grant Visudyne Therapy its first approval

Dec. 20, 1999

Seretide MDI submitted for European marketing approval

Dec. 17, 1999

Novartis files NDA for extended-release formulation of fluvastatin

Dec. 16, 1999

NIH-sponsored study fails to confirm efficacy of secretin in autism

Dec. 14, 1999

Mallinckrodt's MRI contrast agent approved for marketing in U.S.

Dec. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.